NPI: 1831154442 · LOGAN, WV 25601 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/18/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/18/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,889 | $53K |
| 2019 | 4,343 | $128K |
| 2020 | 6,948 | $635K |
| 2021 | 4,842 | $132K |
| 2022 | 2,406 | $35K |
| 2023 | 2,055 | $47K |
| 2024 | 218 | $2K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 9,181 | 796 | $824K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,346 | 737 | $112K |
| J1756 | Injection, iron sucrose, 1 mg | 2,263 | 824 | $64K |
| A4657 | Syringe, with or without needle, each | 595 | 319 | $22K |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,746 | 204 | $8K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 37 | 25 | $845.71 |
| 83970 | 56 | 52 | $676.19 | |
| 82728 | 66 | 64 | $224.43 | |
| 83550 | 67 | 65 | $144.02 | |
| 83540 | 67 | 65 | $106.77 | |
| 85041 | 107 | 102 | $50.57 | |
| 85048 | 63 | 62 | $41.77 | |
| 82108 | 28 | 25 | $6.73 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 79 | 64 | $2.80 |